[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti-inflammatory Therapy Market Growth (Status and Outlook) 2023-2029

March 2023 | 100 pages | ID: G684566B05EAEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

LPI (LP Information)' newest research report, the “Anti-inflammatory Therapy Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Therapy sales for 2023 through 2029. With Anti-inflammatory Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Therapy industry.

This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-inflammatory Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Therapy.

The global Anti-inflammatory Therapy market size is projected to grow from US$ 108140 million in 2022 to US$ 166150 million in 2029; it is expected to grow at a CAGR of 6.3% from 2023 to 2029.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Corticosteroids
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs
  • Others
Segmentation by application
  • Respiratory Diseases
  • Arthritis
  • Gastroenterology
  • Dermatology
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AbbVie
  • Johnson & Johnson
  • Amgen Inc
  • AstraZeneca PLC
  • Pfizer, Inc
  • Novartis
  • Roche
  • Merck
  • Sanofi
  • GlaxoSmithKline
  • Sun Pharmaceutical Industries Ltd
  • TEVA
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-inflammatory Therapy Market Size 2018-2029
  2.1.2 Anti-inflammatory Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti-inflammatory Therapy Segment by Type
  2.2.1 Corticosteroids
  2.2.2 Anti-inflammatory Biologics
  2.2.3 Non-Steroidal Anti-inflammatory Drugs
  2.2.4 Others
2.3 Anti-inflammatory Therapy Market Size by Type
  2.3.1 Anti-inflammatory Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
2.4 Anti-inflammatory Therapy Segment by Application
  2.4.1 Respiratory Diseases
  2.4.2 Arthritis
  2.4.3 Gastroenterology
  2.4.4 Dermatology
  2.4.5 Others
2.5 Anti-inflammatory Therapy Market Size by Application
  2.5.1 Anti-inflammatory Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)

3 ANTI-INFLAMMATORY THERAPY MARKET SIZE BY PLAYER

3.1 Anti-inflammatory Therapy Market Size Market Share by Players
  3.1.1 Global Anti-inflammatory Therapy Revenue by Players (2018-2023)
  3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Anti-inflammatory Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-INFLAMMATORY THERAPY BY REGIONS

4.1 Anti-inflammatory Therapy Market Size by Regions (2018-2023)
4.2 Americas Anti-inflammatory Therapy Market Size Growth (2018-2023)
4.3 APAC Anti-inflammatory Therapy Market Size Growth (2018-2023)
4.4 Europe Anti-inflammatory Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti-inflammatory Therapy Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Anti-inflammatory Therapy Market Size by Country (2018-2023)
5.2 Americas Anti-inflammatory Therapy Market Size by Type (2018-2023)
5.3 Americas Anti-inflammatory Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-inflammatory Therapy Market Size by Region (2018-2023)
6.2 APAC Anti-inflammatory Therapy Market Size by Type (2018-2023)
6.3 APAC Anti-inflammatory Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti-inflammatory Therapy by Country (2018-2023)
7.2 Europe Anti-inflammatory Therapy Market Size by Type (2018-2023)
7.3 Europe Anti-inflammatory Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-inflammatory Therapy by Region (2018-2023)
8.2 Middle East & Africa Anti-inflammatory Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti-inflammatory Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI-INFLAMMATORY THERAPY MARKET FORECAST

10.1 Global Anti-inflammatory Therapy Forecast by Regions (2024-2029)
  10.1.1 Global Anti-inflammatory Therapy Forecast by Regions (2024-2029)
  10.1.2 Americas Anti-inflammatory Therapy Forecast
  10.1.3 APAC Anti-inflammatory Therapy Forecast
  10.1.4 Europe Anti-inflammatory Therapy Forecast
  10.1.5 Middle East & Africa Anti-inflammatory Therapy Forecast
10.2 Americas Anti-inflammatory Therapy Forecast by Country (2024-2029)
  10.2.1 United States Anti-inflammatory Therapy Market Forecast
  10.2.2 Canada Anti-inflammatory Therapy Market Forecast
  10.2.3 Mexico Anti-inflammatory Therapy Market Forecast
  10.2.4 Brazil Anti-inflammatory Therapy Market Forecast
10.3 APAC Anti-inflammatory Therapy Forecast by Region (2024-2029)
  10.3.1 China Anti-inflammatory Therapy Market Forecast
  10.3.2 Japan Anti-inflammatory Therapy Market Forecast
  10.3.3 Korea Anti-inflammatory Therapy Market Forecast
  10.3.4 Southeast Asia Anti-inflammatory Therapy Market Forecast
  10.3.5 India Anti-inflammatory Therapy Market Forecast
  10.3.6 Australia Anti-inflammatory Therapy Market Forecast
10.4 Europe Anti-inflammatory Therapy Forecast by Country (2024-2029)
  10.4.1 Germany Anti-inflammatory Therapy Market Forecast
  10.4.2 France Anti-inflammatory Therapy Market Forecast
  10.4.3 UK Anti-inflammatory Therapy Market Forecast
  10.4.4 Italy Anti-inflammatory Therapy Market Forecast
  10.4.5 Russia Anti-inflammatory Therapy Market Forecast
10.5 Middle East & Africa Anti-inflammatory Therapy Forecast by Region (2024-2029)
  10.5.1 Egypt Anti-inflammatory Therapy Market Forecast
  10.5.2 South Africa Anti-inflammatory Therapy Market Forecast
  10.5.3 Israel Anti-inflammatory Therapy Market Forecast
  10.5.4 Turkey Anti-inflammatory Therapy Market Forecast
  10.5.5 GCC Countries Anti-inflammatory Therapy Market Forecast
10.6 Global Anti-inflammatory Therapy Forecast by Type (2024-2029)
10.7 Global Anti-inflammatory Therapy Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Anti-inflammatory Therapy Product Offered
  11.1.3 AbbVie Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Anti-inflammatory Therapy Product Offered
  11.2.3 Johnson & Johnson Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Amgen Inc
  11.3.1 Amgen Inc Company Information
  11.3.2 Amgen Inc Anti-inflammatory Therapy Product Offered
  11.3.3 Amgen Inc Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Amgen Inc Main Business Overview
  11.3.5 Amgen Inc Latest Developments
11.4 AstraZeneca PLC
  11.4.1 AstraZeneca PLC Company Information
  11.4.2 AstraZeneca PLC Anti-inflammatory Therapy Product Offered
  11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 AstraZeneca PLC Main Business Overview
  11.4.5 AstraZeneca PLC Latest Developments
11.5 Pfizer, Inc
  11.5.1 Pfizer, Inc Company Information
  11.5.2 Pfizer, Inc Anti-inflammatory Therapy Product Offered
  11.5.3 Pfizer, Inc Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Pfizer, Inc Main Business Overview
  11.5.5 Pfizer, Inc Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Anti-inflammatory Therapy Product Offered
  11.6.3 Novartis Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Roche
  11.7.1 Roche Company Information
  11.7.2 Roche Anti-inflammatory Therapy Product Offered
  11.7.3 Roche Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Roche Main Business Overview
  11.7.5 Roche Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Anti-inflammatory Therapy Product Offered
  11.8.3 Merck Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Sanofi
  11.9.1 Sanofi Company Information
  11.9.2 Sanofi Anti-inflammatory Therapy Product Offered
  11.9.3 Sanofi Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Sanofi Main Business Overview
  11.9.5 Sanofi Latest Developments
11.10 GlaxoSmithKline
  11.10.1 GlaxoSmithKline Company Information
  11.10.2 GlaxoSmithKline Anti-inflammatory Therapy Product Offered
  11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 GlaxoSmithKline Main Business Overview
  11.10.5 GlaxoSmithKline Latest Developments
11.11 Sun Pharmaceutical Industries Ltd
  11.11.1 Sun Pharmaceutical Industries Ltd Company Information
  11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product Offered
  11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
  11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.12 TEVA
  11.12.1 TEVA Company Information
  11.12.2 TEVA Anti-inflammatory Therapy Product Offered
  11.12.3 TEVA Anti-inflammatory Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 TEVA Main Business Overview
  11.12.5 TEVA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Anti-inflammatory Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Corticosteroids
Table 3. Major Players of Anti-inflammatory Biologics
Table 4. Major Players of Non-Steroidal Anti-inflammatory Drugs
Table 5. Major Players of Others
Table 6. Anti-inflammatory Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Anti-inflammatory Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Table 9. Anti-inflammatory Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Anti-inflammatory Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Table 12. Global Anti-inflammatory Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Anti-inflammatory Therapy Revenue Market Share by Player (2018-2023)
Table 14. Anti-inflammatory Therapy Key Players Head office and Products Offered
Table 15. Anti-inflammatory Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-inflammatory Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Anti-inflammatory Therapy Market Size Market Share by Regions (2018-2023)
Table 20. Global Anti-inflammatory Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Anti-inflammatory Therapy Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Anti-inflammatory Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Anti-inflammatory Therapy Market Size Market Share by Country (2018-2023)
Table 24. Americas Anti-inflammatory Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Table 26. Americas Anti-inflammatory Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Table 28. APAC Anti-inflammatory Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Anti-inflammatory Therapy Market Size Market Share by Region (2018-2023)
Table 30. APAC Anti-inflammatory Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Table 32. APAC Anti-inflammatory Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Table 34. Europe Anti-inflammatory Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Anti-inflammatory Therapy Market Size Market Share by Country (2018-2023)
Table 36. Europe Anti-inflammatory Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Table 38. Europe Anti-inflammatory Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Anti-inflammatory Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Anti-inflammatory Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Anti-inflammatory Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Anti-inflammatory Therapy
Table 47. Key Market Challenges & Risks of Anti-inflammatory Therapy
Table 48. Key Industry Trends of Anti-inflammatory Therapy
Table 49. Global Anti-inflammatory Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Anti-inflammatory Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Anti-inflammatory Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Anti-inflammatory Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. AbbVie Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 54. AbbVie Anti-inflammatory Therapy Product Offered
Table 55. AbbVie Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 59. Johnson & Johnson Anti-inflammatory Therapy Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Johnson & Johnson Latest Developments
Table 63. Amgen Inc Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 64. Amgen Inc Anti-inflammatory Therapy Product Offered
Table 65. Amgen Inc Main Business
Table 66. Amgen Inc Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Amgen Inc Latest Developments
Table 68. AstraZeneca PLC Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 69. AstraZeneca PLC Anti-inflammatory Therapy Product Offered
Table 70. AstraZeneca PLC Main Business
Table 71. AstraZeneca PLC Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. AstraZeneca PLC Latest Developments
Table 73. Pfizer, Inc Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 74. Pfizer, Inc Anti-inflammatory Therapy Product Offered
Table 75. Pfizer, Inc Main Business
Table 76. Pfizer, Inc Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer, Inc Latest Developments
Table 78. Novartis Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 79. Novartis Anti-inflammatory Therapy Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Novartis Latest Developments
Table 83. Roche Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 84. Roche Anti-inflammatory Therapy Product Offered
Table 85. Roche Main Business
Table 86. Roche Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Roche Latest Developments
Table 88. Merck Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 89. Merck Anti-inflammatory Therapy Product Offered
Table 90. Merck Main Business
Table 91. Merck Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Merck Latest Developments
Table 93. Sanofi Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 94. Sanofi Anti-inflammatory Therapy Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Sanofi Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-inflammatory Therapy Product Offered
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. GlaxoSmithKline Latest Developments
Table 103. Sun Pharmaceutical Industries Ltd Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 104. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product Offered
Table 105. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Sun Pharmaceutical Industries Ltd Main Business
Table 107. Sun Pharmaceutical Industries Ltd Latest Developments
Table 108. TEVA Details, Company Type, Anti-inflammatory Therapy Area Served and Its Competitors
Table 109. TEVA Anti-inflammatory Therapy Product Offered
Table 110. TEVA Main Business
Table 111. TEVA Anti-inflammatory Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. TEVA Latest Developments

LIST OF FIGURES

Figure 1. Anti-inflammatory Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-inflammatory Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti-inflammatory Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti-inflammatory Therapy Sales Market Share by Country/Region (2022)
Figure 8. Anti-inflammatory Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti-inflammatory Therapy Market Size Market Share by Type in 2022
Figure 10. Anti-inflammatory Therapy in Respiratory Diseases
Figure 11. Global Anti-inflammatory Therapy Market: Respiratory Diseases (2018-2023) & ($ Millions)
Figure 12. Anti-inflammatory Therapy in Arthritis
Figure 13. Global Anti-inflammatory Therapy Market: Arthritis (2018-2023) & ($ Millions)
Figure 14. Anti-inflammatory Therapy in Gastroenterology
Figure 15. Global Anti-inflammatory Therapy Market: Gastroenterology (2018-2023) & ($ Millions)
Figure 16. Anti-inflammatory Therapy in Dermatology
Figure 17. Global Anti-inflammatory Therapy Market: Dermatology (2018-2023) & ($ Millions)
Figure 18. Anti-inflammatory Therapy in Others
Figure 19. Global Anti-inflammatory Therapy Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Anti-inflammatory Therapy Market Size Market Share by Application in 2022
Figure 21. Global Anti-inflammatory Therapy Revenue Market Share by Player in 2022
Figure 22. Global Anti-inflammatory Therapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Anti-inflammatory Therapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Anti-inflammatory Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Anti-inflammatory Therapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Anti-inflammatory Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Anti-inflammatory Therapy Value Market Share by Country in 2022
Figure 28. United States Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Anti-inflammatory Therapy Market Size Market Share by Region in 2022
Figure 33. APAC Anti-inflammatory Therapy Market Size Market Share by Type in 2022
Figure 34. APAC Anti-inflammatory Therapy Market Size Market Share by Application in 2022
Figure 35. China Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Anti-inflammatory Therapy Market Size Market Share by Country in 2022
Figure 42. Europe Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Anti-inflammatory Therapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Anti-inflammatory Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 65. China Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 69. India Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 72. France Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Anti-inflammatory Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Anti-inflammatory Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-inflammatory Therapy Market Size Market Share Forecast by Application (2024-2029)


More Publications